Global Exploration of Genomic Elements in Autoimmunity
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the National Human Genome Research Institute (NHGRI), has issued a Presolicitation (Notice of Intent) to award a non-competitive contract to Inbiomedic SAC. This contract is for professional services supporting the "Global Exploration of Genomic Elements in Autoimmunity" research. The goal is to establish well-characterized participant cohorts with autoimmune diseases in understudied global populations. While a single-source award is intended, interested parties may submit capability statements by June 27, 2026, at 9:00 AM ET.
Purpose & Scope
The NIH, through its Medical Genetics Branch (MGB) and the Genomics of Autoimmune Rheumatic Disease Section (GARDS), studies genetic, genomic, environmental, clinical, and metabolic factors in autoimmune diseases. GARDS requires professional services to develop collaborations and community engagement activities. These efforts are crucial for establishing participant cohorts in understudied global populations, which will enhance understanding of disease risk, severity, and genetic factors contributing to autoimmune conditions.
Contract Details
- Opportunity Type: Presolicitation (Notice of Intent for non-competitive award)
- Intended Awardee: Inbiomedic SAC
- NAICS Code: 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)) with a size standard of $34 Million.
- Procurement Authority: FAR Subpart 13-Simplified Acquisition Procedures, specifically FAR 13.106-1(b)(1) for soliciting from a single source.
- Estimated Value: Not to exceed the simplified acquisition threshold ($350,000).
- Set-Aside: None (Non-competitive, single source intended).
- Place of Performance: Bethesda, MD, United States (NIH office location).
Submission & Response
This is not a request for competitive proposals. However, interested parties who believe they can meet the requirement may identify their interest and capability. Responses must include a technical proposal, cost-price proposal, proposed period of performance, Unique Entity ID (UEI), Taxpayer Identification Number (TIN), and certification of business size. All offerors must have an active registration in SAM.gov. The government reserves the discretion to not compete the contract based on responses received.
Key Dates & Contact
- Response Deadline: June 27, 2026, at 9:00 AM Eastern Time.
- Submission Method: Electronically to Mr. Vishnuvajjala Hanumanth Rao at vishnuh@mail.nih.gov or via fax.
- Primary Contact: Vishnuvajjala Hanumanth Rao (vishnuh@mail.nih.gov).